Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2024-12-29 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
第五届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Beijing Kangle Weishi Biotechnology Co., Ltd. It details the meeting date, attendance, and the approval of proposals related to bank credit applications and guarantees. The content focuses on internal governance decisions and approvals rather than financial results, audit opinions, or regulatory filings. There is no indication of financial statements or detailed financial data. The document is not a full report but a formal announcement of board resolutions. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management.
2024-12-29 Chinese
关于公司及子公司银行授信暨关联交易公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's and its subsidiaries' bank credit facilities and related party transactions. It details the application for credit lines, guarantees provided by related parties, board and supervisory committee approvals, and the nature and fairness of the transactions. There are no financial statements or comprehensive financial data presented. The document is a regulatory announcement about financing and related party guarantees, not a full financial report or earnings release. It fits best under Capital/Financing Update (CAP) as it concerns updates on company financing activities and credit arrangements.
2024-12-29 Chinese
第五届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fifth board of directors' fourth meeting of Beijing Kangle Weishi Biotechnology Co., Ltd. It details the meeting's convening, attendance, and the approval of specific financing-related proposals, including bank credit applications and guarantees. The content focuses on board decisions and meeting procedures rather than financial results, audit opinions, or shareholder voting outcomes. It does not contain financial statements or detailed financial analysis, nor is it a transcript or presentation. The document is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1927 characters), and it is not merely an announcement of a report publication but the actual meeting resolution content. Therefore, the appropriate classification is MANG with high confidence.
2024-12-29 Chinese
关于完成工商变更登记并取得营业执照的公告
Board/Management Information Classification · 95% confidence The document is an official announcement regarding the completion of business registration changes and obtaining a new business license. It details changes in the company's board of directors, supervisory board, and senior management appointments, including the appointment of a new legal representative. The document references prior announcements about governance and board changes but itself is focused on the registration update and management changes. It does not contain financial data, earnings, or detailed reports. The primary content is about management and board changes and official registration updates. Therefore, the most appropriate classification is 'Board/Management Information (MANG)'. The document length is short (1298 characters), and it is not a report publication announcement or regulatory filing. Confidence is high due to clear content focus on management and board changes.
2024-12-19 Chinese
中信证券股份有限公司关于北京康乐卫士生物技术股份有限公司子公司申请银行授信暨公司提供反担保的核查意见
Regulatory Filings
2024-12-05 Chinese
第五届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the third meeting of the fifth board of directors of Beijing Kangle Weishi Biotechnology Co., Ltd. It details the meeting's attendance, agenda items, voting results, and compliance with legal and procedural requirements. The content focuses on board decisions regarding the use of idle raised funds and bank credit applications by a subsidiary, with no indication of a full annual or interim financial report, audit report, or earnings release. It is not a call transcript, investor presentation, or regulatory filing of another type. The document is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1572 characters), and it contains substantive content about board decisions, not just a notice or report publication announcement.
2024-12-03 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.